FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1000 September 27, 2001 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Rituximab is a chimeric monoclonal antibody directed against the CD20 antigen expressed on most B cells and is used to treat B-cell non-Hodgkin's lymphoma.¹ Recently, rituximab has been used to treat post-transplantation lymphoproliferative disorders, which may occur after solid-organ and bone marrow transplantation; the prognosis associated with these disorders is usually poor, even if the doses of immunosuppressive drugs are reduced. Rituximab induces profound and durable B-cell depletion without a substantial decrease in serum immunoglobulin levels. Viral infection has rarely been reported after the use of this agent. Hepatitis B reactivation,^1,2 visceral varicella–zoster infection,³ and pure red-cell . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Heslop, H. E. (2009). How I treat EBV lymphoproliferation. Blood 114: 4002-4008 [Abstract] [Full Text]  
• Yeo, W., Chan, T. C., Leung, N. W.Y., Lam, W. Y., Mo, F. K.F., Chu, M. T., Chan, H. L.Y., Hui, E. P., Lei, K. I.K., Mok, T. S.K., Chan, P. K.S. (2009). Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab. JCO 27: 605-611 [Abstract] [Full Text]  
• Lovric, S., Erdbruegger, U., Kumpers, P., Woywodt, A., Koenecke, C., Wedemeyer, H., Haller, H., Haubitz, M. (2009). Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrol Dial Transplant 24: 179-185 [Abstract] [Full Text]  
• Straathof, K. C.M., Bollard, C. M., Rooney, C. M., Heslop, H. E. (2003). Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children. The Oncologist 8: 83-98 [Abstract] [Full Text]  
• Lowndes, S., Darby, A., Mead, G., Lister, A. (2002). Stevens-Johnson syndrome after treatment with rituximab. Ann Oncol 13: 1948-1950 [Abstract] [Full Text]  
• Wiestner, A., Cho, H. J., Asch, A. S., Michelis, M. A., Zeller, J. A., Peerschke, E. I. B., Weksler, B. B., Schechter, G. P. (2002). Rituximab in the treatment of acquired factor VIII inhibitors. Blood 100: 3426-3428 [Abstract] [Full Text]